BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

524606

BERLDRG

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

BERYL DRUGS LTD. Share Price Update

As of the latest trading session, BERYL DRUGS LTD. share price is currently at ₹ 20.29, which is down by ₹ -0.82 from its previous closing. Today, the stock has fluctuated between ₹ 20.07 and ₹ 21.12. Over the past year, BERYL DRUGS LTD. has achieved a return of -42.42 %. In the last month alone, the return has been -4.96 %. Read More...

BERYL DRUGS LTD. fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    10.30

  • P/E Ratio (TTM)

    126.81

  • Beta

    0.33

  • Book Value / share

    18.29

  • Return on equity

    9.07%

  • EPS (TTM)

    0.16

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    0.05

info icon alternate text

BERYL DRUGS LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 5.31
Operating Expense 5.24
Net Profit 0.05
Net Profit Margin (%) 0.94
Earnings Per Share (EPS) 0.10
EBITDA 0.59
Effective Tax Rate (%) 68.75
Particulars SEP 2024 (Values in Cr)
Revenue 5.61
Operating Expense 5.53
Net Profit 0.01
Net Profit Margin (%) 0.17
Earnings Per Share (EPS) 0.01
EBITDA 0.56
Effective Tax Rate (%) 90.90
Particulars JUN 2024 (Values in Cr)
Revenue 6.25
Operating Expense 5.79
Net Profit 0.37
Net Profit Margin (%) 5.92
Earnings Per Share (EPS) 0.73
EBITDA 0.99
Effective Tax Rate (%) 26.00
Particulars MAR 2024 (Values in Cr)
Revenue 2.98
Operating Expense 3.63
Net Profit -0.35
Net Profit Margin (%) -11.74
Earnings Per Share (EPS) -0.68
EBITDA 0.03
Effective Tax Rate (%) 19.04
Particulars DEC 2023 (Values in Cr)
Revenue 7.62
Operating Expense 7.28
Net Profit 0.31
Net Profit Margin (%) 4.06
Earnings Per Share (EPS) 0.61
EBITDA 0.80
Effective Tax Rate (%) 18.42
Particulars MAR 2024 (Values in Cr)
Revenue 26.73
Operating Expense 26.11
Net Profit 0.77
Net Profit Margin (%) 2.88
Earnings Per Share (EPS) 1.52
EBITDA 2.67
Effective Tax Rate (%) 23.76
Particulars MAR 2023 (Values in Cr)
Revenue 26.89
Operating Expense 26.18
Net Profit 0.77
Net Profit Margin (%) 2.86
Earnings Per Share (EPS) 1.52
EBITDA 2.21
Effective Tax Rate (%) 22.44
Particulars MAR 2022 (Values in Cr)
Revenue 14.60
Operating Expense 15.71
Net Profit -0.66
Net Profit Margin (%) -4.52
Earnings Per Share (EPS) -1.30
EBITDA 0.58
Effective Tax Rate (%) 30.52
Particulars MAR 2021 (Values in Cr)
Revenue 14.09
Operating Expense 14.39
Net Profit 0.24
Net Profit Margin (%) 1.70
Earnings Per Share (EPS) 0.47
EBITDA 2.09
Effective Tax Rate (%) 31.42
Particulars MAR 2020 (Values in Cr)
Revenue 12.82
Operating Expense 12.89
Net Profit 0.05
Net Profit Margin (%) 0.39
Earnings Per Share (EPS) 0.09
EBITDA 1.14
Effective Tax Rate (%) 68.75
Particulars MAR 2024 (Values in Cr)
Book Value / Share 17.52
ROE % 9.07
ROCE % 11.38
Total Debt to Total Equity 0.57
EBITDA Margin 10.33
Particulars MAR 2023 (Values in Cr)
Book Value / Share 15.84
ROE % 10.03
ROCE % 10.76
Total Debt to Total Equity 0.64
EBITDA Margin 8.44
Particulars MAR 2022 (Values in Cr)
Book Value / Share 14.32
ROE % -8.67
ROCE % -3.56
Total Debt to Total Equity 0.68
EBITDA Margin 4.11
Particulars MAR 2021 (Values in Cr)
Book Value / Share 15.57
ROE % -1.29
ROCE % 2.79
Total Debt to Total Equity 0.67
EBITDA Margin 11.64
Particulars MAR 2020 (Values in Cr)
Book Value / Share 14.97
ROE % 0.66
ROCE % 3.98
Total Debt to Total Equity 0.56
EBITDA Margin 8.89
Particulars MAR 2024 (Values in Cr)
Net Income 1.00
Cash from Operations 1.02
Cash from Investing -1.08
Cash from Financing 0.10
Net change in Cash -0.15
Free Cash Flow 2.37
Particulars MAR 2023 (Values in Cr)
Net Income 0.98
Cash from Operations 2.54
Cash from Investing -1.30
Cash from Financing -1.16
Net change in Cash 0.01
Free Cash Flow 4.10
Particulars MAR 2022 (Values in Cr)
Net Income -0.95
Cash from Operations -0.43
Cash from Investing 0.52
Cash from Financing -0.23
Net change in Cash -0.18
Free Cash Flow -0.02
Particulars MAR 2021 (Values in Cr)
Net Income 0.34
Cash from Operations 0.36
Cash from Investing 0.25
Cash from Financing -0.53
Net change in Cash 0.05
Free Cash Flow 1.41
Particulars MAR 2020 (Values in Cr)
Net Income 0.15
Cash from Operations 0.33
Cash from Investing -1.55
Cash from Financing 1.66
Net change in Cash 0.29
Free Cash Flow 2.20
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 19.60 1.99 279.41 34.11 / 77.70
BLISS GVS PHARMA LTD 119.00 15.60 1.24 1253.91 92.25 / 184.95
CIPLA LTD 1549.65 25.08 4.41 125155.99 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 260.70 21.60 2.64 767.27 145.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2959.45 58.70 29.97 50134.87 1924.30 / 3147.45
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 21.96 6.19 279.41 34.11 / 77.70
AMRUTAJAN HEALTH LTD 692.80 40.61 6.72 2002.93 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8665.50 129.24 31.88 21663.75 5000.00 / 9199.00
BLISS GVS PHARMA LTD 119.00 15.45 1.22 1253.91 92.25 / 184.95

BERYL DRUGS LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
20.29 -3.92 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 21.50
  • 26 Days 22.90
  • 10 Days 22.00
  • 50 Days 24.80
  • 12 Days 22.10
  • 100 Days 28.00
  • 20 Days 22.50
  • 200 Days 30.10
21.73 PIVOT

First Support

20.49

First Resistance

22.37

Second Support

19.85

Second Resistance

23.61

Third Support

18.61

Third Resistance

24.25

RSI

34.41

ADX

12.89

MACD

-0.79

Williams % R

-94.10

Commodity Channel Index (CCI)

-244.72

Date

2025-04-30

Week

1124.00

Same Day

4518.00

Month

1408.00

1 Year

0.33

3 Year

0.49

Over 1 Month

-4.96%

down

Over 1 Year

-42.42%

down

Over 3 Months

-42.84%

down

Over 3 Years

29.23%

down

Over 6 Months

-45.47%

down

Over 5 Years

37.68%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

BERYL DRUGS LTD. shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
73.61%
Promoter Holdings
26.38%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Sanjay Sethi 551800.0 (10.88%) Shareholding of Promoter and Promoter Group
Sudhir Sethi 438504.0 (8.65%) Shareholding of Promoter and Promoter Group
Samir Narendra Gupta 205081.0 (4.04%) Public Shareholding
Sangita Sethi 191935.0 (3.78%) Shareholding of Promoter and Promoter Group
Soniya Sethi 155896.0 (3.07%) Shareholding of Promoter and Promoter Group
Mayank Siyal 104865.0 (2.07%) Public Shareholding
Jinesh Joseph 84796.0 (1.67%) Public Shareholding
Punjabhai Keshavbhai Jadeja 62511.0 (1.23%) Public Shareholding
R. B. Vijay 60250.0 (1.19%) Public Shareholding
Simimon Kallupurackal Joby 53335.0 (1.05%) Public Shareholding

News

Left Arrow
Right Arrow

BERYL DRUGS LTD. corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

BERYL DRUGS LTD. Share Price

Beryl Drugs Limited, based in Indore, was incorporated on August 24, 1993. The Company acquired the running business of M/s Flora and Fauna Remedies Limited on December 15, 1993. The Shares of Company were listed on M.P. Stock Exchange, Bombay Stock Exchange and Ahmedabad Stock Exchange.

The Company thereafter has been engaged in the manufacture, sale, and export of branded, generic pharmaceutical formulations in India and internationally. It offers I.V.fluids, and a range of small and large volume injectables. It provides a range of eye/ear drops, veterinary products, and injections. It sells products through sales and distribution network. In addition, it offers research and development, as well as contract manufacturing services. Beryl Drugs Ltd. is based in Indore, India.

Beryl emerged into a global network of pharmaceutical manufacturing, research and development, contract manufacturing services and veterinary products. It owns brands like BERI-CEF injection, F-Neuron, Amplicillin INJ, P-Mol, Biprox, B-Flox and many more.

The manufacturing facilities of the Company are in compliance with WHO GMP specifications. The Company is in tune with the current manufacturing trends in healthcare industry. The Company is an ISO 9001:2000 certified for quality management, which acknowledges quality as the first and the foremost important aspect into the business of healthcare products.

Parent organization Indian Private
NSE symbol [-]
Founded 1993
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Beryl Drugs Ltd?

Answer Field

The share price of Beryl Drugs Ltd for NSE is ₹ 0.00 and for BSE is ₹ 20.29.

What is the Market Cap of Beryl Drugs Ltd?

Answer Field

The market cap of Beryl Drugs Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 10.30 Cr. as of now.

What is the 52 Week High and Low of Beryl Drugs Ltd?

Answer Field

The 52 Week High and Low of Beryl Drugs Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 46.00 and ₹ 20.07.

How to Buy Beryl Drugs Ltd share?

Answer Field

You can trade in Beryl Drugs Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Beryl Drugs Ltd?

Answer Field

The 1 year returns on the stock has been -42.42%.

What is the Current Share Price of Beryl Drugs Ltd?

Answer Field

Beryl Drugs Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 20.29 as on Apr 30 2025 03:25 PM.

What is the Market Cap of Beryl Drugs Ltd Share?

Answer Field

The market cap of Beryl Drugs Ltd for NSE ₹ 0.0 & for BSE ₹ 10.30 as on Apr 30 2025 03:25 PM.

What is the P/E Ratio of Beryl Drugs Ltd Share?

Answer Field

As on Apr 30 2025 03:25 PM the price-to-earnings (PE) ratio for Beryl Drugs Ltd share is 126.81.

What is the PB ratio of Beryl Drugs Ltd Share?

Answer Field

As on Apr 30 2025 03:25 PM, the price-to-book (PB) ratio for Beryl Drugs Ltd share is 18.29.

How to Buy Beryl Drugs Ltd Share?

Answer Field

You can trade in Beryl Drugs Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Beryl Drugs Ltd Share on Bajaj Broking App?

Answer Field

To buy Beryl Drugs Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Beryl Drugs Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|